We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Nanomedicine and Nanotechnology”. The paper list is as follows:

1. “Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application”
by Domenico Lombardo and Mikhail A. Kiselev
Pharmaceutics 2022, 14(3), 543; https://doi.org/10.3390/pharmaceutics14030543
Available online: https://www.mdpi.com/1999-4923/14/3/543

2. “An Overview of Nanotechnologies for Drug Delivery to the Brain”
by Ahsan Ayub and Shawn Wettig
Pharmaceutics 2022, 14(2), 224; https://doi.org/10.3390/pharmaceutics14020224
Available online: https://www.mdpi.com/1999-4923/14/2/224

3. “Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma”
by Maria João Ramalho, Joana Angélica Loureiro, Manuel A. N. Coelho and Maria Carmo Pereira
Pharmaceutics 2022, 14(2), 279; https://doi.org/10.3390/pharmaceutics14020279
Available online: https://www.mdpi.com/1999-4923/14/2/279

4. “Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation”
by Hanhee Cho, Seong Ik Jeon, Cheol-Hee Ahn, Man Kyu Shim and Kwangmeyung Kim
Pharmaceutics 2022, 14(4), 728; https://doi.org/10.3390/pharmaceutics14040728
Available online: https://www.mdpi.com/1999-4923/14/4/728

5. “Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release”
by Avelino Corma, Pablo Botella and Eva Rivero-Buceta
Pharmaceutics 2022, 14(1), 110; https://doi.org/10.3390/pharmaceutics14010110
Available online: https://www.mdpi.com/1999-4923/14/1/110

6. “Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment”
by Hyeji Lee, Kanghye Bae, Ah-Rum Baek, Eun-Bin Kwon, Yeoun-Hee Kim, Sung-Wook Nam, Gang Ho Lee and Yongmin Chang
Pharmaceutics 2022, 14(5), 1002; https://doi.org/10.3390/pharmaceutics14051002
Available online: https://www.mdpi.com/1999-4923/14/5/1002

7. “Superparamagnetic Iron Oxide Nanoparticles Decorated Mesoporous Silica Nanosystem for Combined Antibiofilm Therapy”
by Elena Álvarez, Manuel Estévez, Alvaro Gallo-Cordova, Blanca González, Rafael R. Castillo, María del Puerto Morales, Montserrat Colilla, Isabel Izquierdo-Barba and María Vallet-Regí
Pharmaceutics 2022, 14(1), 163; https://doi.org/10.3390/pharmaceutics14010163
Available online: https://www.mdpi.com/1999-4923/14/1/163

8. “mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy”
by Kosuke Sasaki, Yusuke Sato, Kento Okuda, Kazuki Iwakawa and Hideyoshi Harashima
Pharmaceutics 2022, 14(8), 1572; https://doi.org/10.3390/pharmaceutics14081572
Available online: https://www.mdpi.com/1999-4923/14/8/1572

9. “Cu-Doped Hollow Bioactive Glass Nanoparticles for Bone Infection Treatment”
by Javier Jiménez-Holguín, Sandra Sánchez-Salcedo, Mónica Cicuéndez, María Vallet-Regí and Antonio J. Salinas
Pharmaceutics 2022, 14(4), 845; https://doi.org/10.3390/pharmaceutics14040845
Available online: https://www.mdpi.com/1999-4923/14/4/845

10. “A Unique Core—Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects”
by Bei Cheng, Hye-Hyun Ahn, Hwanhee Nam, Zirui Jiang, Feng J. Gao, Il Minn and Martin G. Pomper
Pharmaceutics 2022, 14(2), 373; https://doi.org/10.3390/pharmaceutics14020373
Available online: https://www.mdpi.com/1999-4923/14/2/373

You can check all publications in the Section “Nanomedicine and Nanotechnology” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1027.